Raleigh named among best cities for asthma, but scores a ‘D’ for smog – Triangle Business Journal (blog)

Raleigh named among best cities for asthma, but scores a 'D' for smog
Triangle Business Journal (blog)
According to Nerdwallet's analysis of asthma data from the Centers for Disease Control and Prevention, Raleigh is ranked the eighth-best city for asthma sufferers, yet ended up with a smog grade of "D." Among the 50 metros analyzed, only Arlington, Va

and more »

View full post on asthma – Google News

Roche scores upbeat data for a personalized asthma drug with blockbuster hopes – FierceBiotech


Drug Discovery & Development

Roche scores upbeat data for a personalized asthma drug with blockbuster hopes
FierceBiotech
Roche's ($RHHBY) lebrikizumab significantly reduced the rate of asthma attacks in patients with a severe form of the disease, according to mid-stage trial results, lighting the way for a Phase III study on the novel, personalized treatment. The drug
Biologic May Tame Severe AsthmaMedPage Today
Roche drug cuts asthma attacks, improves lung function -studyReuters
Lebrikizumab Phase 2b Data Show Reduction of Asthma Attack RatesDrug Discovery & Development
PharmaTimes
all 12 news articles »

View full post on asthma – Google News

Kansas Scores Low In School Asthma, Allergy Report – KAKE

Kansas Scores Low In School Asthma, Allergy Report
KAKE
A new report ranks Kansas near the bottom, when it comes to policies helping students with asthma and food allergies. The Asthma and Allergy Foundation of America rated states on 18 core standards. It judged Kansas as meeting only seven of them. Kansas 
Indiana makes honor roll on asthma, allergy policiesWLFI.com
Asthma/Allergy Emergencies in PaWTAJ
New Report Shows Most States Fall Behind on Asthma and Allergy School PoliciesPR Newswire (press release)
WFMJ
all 5 news articles »

View full post on asthma – Google News

Array BioPharma scores midstage success for asthma drug – FierceBiotech

Array BioPharma scores midstage success for asthma drug
FierceBiotech
Array BioPharma has another asset on deck for a potential partnership. The Boulder, CO-based drug developer has touted upbeat Phase II data for an experimental drug in patients with allergic asthma, and the company ($ARRY) plans to seek a partner to 
Array asthma drug meets main goal in mid-stage studyReuters
Array BioPharma: Study Shows Asthma Candidate ARRY-502 Improves Lung Wall Street Journal
Array Seeks Asthma Drug Partner Following Mid-Stage Study ResultsTheStreet.com
RTT News –Benzinga –Yahoo! News
all 8 news articles »

View full post on asthma – Google News